We bring pharma-quality standards of cannabis API for the benefit of Patients in Europe. CBD, short for Cannabidiol, is a chemical compound from the Cannabis sativa plant. It has no psychotropic effects due to it is affinity for cannabinoid receptors CB1 and CB2 and which are part of the endocannabinoid system (ECS).
Pharmacological effect comprehends according to the medical literature positives effects in different autoimmune and neurogenerative pathologies such as multiple sclerosis (spasticity), arthritis, epilepsy (Lennox-Gastaut Syndrome and Dravet Syndrome), schizophrenia and other psychiatric disorders.
TIEFENBACHER API + INGREDIENTS can offer a CBD – white, crystalline substance isolated from industrial hemp in its purest form – manufactured in Europe with a purity > 99,5%, and an impurity profile of THC < 0,01%. By that minimizing side effects for patients.
Our partner for natural CBD is having a MHRA certified EU GMP certificate for both, human and veterinary use and complies with the requirements of the German Medicines Codex (DAC).
TIEFENBACHER API + INGREDIENTS covers the entire supply chain for medical cannabis with the highest pharmaceutical standards. For more information, please contact TIEFENBACHER API + INGREDIENTS: Patricia Wick p.wick@tifi-api.eu
